166 related articles for article (PubMed ID: 33649842)
61. Thyroid Cancer: Risk-Stratified Management and Individualized Therapy.
Raue F; Frank-Raue K
Clin Cancer Res; 2016 Oct; 22(20):5012-5021. PubMed ID: 27742787
[TBL] [Abstract][Full Text] [Related]
62. LONG-TERM OUTCOMES AND PROGNOSTIC FACTORS IN PATIENTS WITH DIFFERENTIATED THYROID CANCER AND DISTANT METASTASES.
Hirsch D; Levy S; Tsvetov G; Gorshtein A; Slutzky-Shraga I; Akirov A; Robenshtok E; Shimon I; Benbassat CA
Endocr Pract; 2017 Oct; 23(10):1193-1200. PubMed ID: 28704099
[TBL] [Abstract][Full Text] [Related]
63. Practical Initial Risk Stratification Based on Lymph Node Metastases in Pediatric and Adolescent Differentiated Thyroid Cancer.
Jeon MJ; Kim YN; Sung TY; Hong SJ; Cho YY; Kim TY; Shong YK; Kim WB; Kim SW; Chung JH; Kim TH; Kim WG
Thyroid; 2018 Feb; 28(2):193-200. PubMed ID: 29179646
[TBL] [Abstract][Full Text] [Related]
64. Contemporary considerations in adjuvant radioiodine treatment of adults with differentiated thyroid cancer.
Juweid ME; Tulchinsky M; Mismar A; Momani M; Zayed AA; Al Hawari H; Albsoul N; Mottaghy FM
Int J Cancer; 2020 Nov; 147(9):2345-2354. PubMed ID: 32319676
[TBL] [Abstract][Full Text] [Related]
65. Differentiated thyroid carcinoma: presentation and follow-up in children and adolescents.
Papendieck P; Gruñeiro-Papendieck L; Venara M; Acha O; Maglio S; Bergadá I; Chiesa A
J Pediatr Endocrinol Metab; 2011; 24(9-10):743-8. PubMed ID: 22145467
[TBL] [Abstract][Full Text] [Related]
66. Evidence-based review of treatment and follow up of pediatric patients with differentiated thyroid carcinoma.
Rachmiel M; Charron M; Gupta A; Hamilton J; Wherrett D; Forte V; Daneman D
J Pediatr Endocrinol Metab; 2006 Dec; 19(12):1377-93. PubMed ID: 17252690
[TBL] [Abstract][Full Text] [Related]
67. Post-treatment surveillance of thyroid cancer.
Wang LY; Ganly I
Eur J Surg Oncol; 2018 Mar; 44(3):357-366. PubMed ID: 28754228
[TBL] [Abstract][Full Text] [Related]
68. Evaluating the influence of prophylactic central neck dissection on TNM staging and the recurrence risk stratification of cN0 differentiated thyroid carcinoma.
Lin X; Chen X; Jiru Y; Du J; Zhao G; Wu Z
Bull Cancer; 2016 Jun; 103(6):535-40. PubMed ID: 27236850
[TBL] [Abstract][Full Text] [Related]
69. Clinical outcomes and prognostic factors in patients with no less than three distant organ system metastases from differentiated thyroid carcinoma.
Zhang XY; Sun JW; Qiu ZL; Wang Y; Chen XY; Zhao JH; Luo QY
Endocrine; 2019 Nov; 66(2):254-265. PubMed ID: 31317522
[TBL] [Abstract][Full Text] [Related]
70. Disease Severity at Presentation in Patients with Disease-Related Mortality from Differentiated Thyroid Cancer: Implications for the 2015 ATA Guidelines.
Robenshtok E; Nachalon Y; Benbassat C; Hirsch D; Shimon I; Grossman A; Diker-Cohen T; Akirov A; Popovtzer A
Thyroid; 2017 Sep; 27(9):1171-1176. PubMed ID: 28791923
[TBL] [Abstract][Full Text] [Related]
71. Thyroid cancer in children and adolescents.
Vander Poorten V; Hens G; Delaere P
Curr Opin Otolaryngol Head Neck Surg; 2013 Apr; 21(2):135-42. PubMed ID: 23486378
[TBL] [Abstract][Full Text] [Related]
72. [Diagnosis and treatment of thyroid cancer in children in the multicenter analysis in Poland for PPGGL].
Prokurat AI; Chrupek M; Pacholska M; Gałazka P; Harasymczuk J; Jankowski A; Niedziela M; Korman E; Kozłowicz-Gudzińska I; Czetwertyńska M; Kaliciński P; Polnik D; Starzyk J; Kalicka-Kasperczyk A; Czernik J; Sawicz-Birkowska K; Bagłaj M; Balcerska A; Stefanowicz J; Birkholz D; Pomorski L; Kaczka K; Peregud-Pogorzelski J; Petriczko E; Godziński J; Ptaszyńska J; Ziemniak B; Woźniak W; Bilska K; Górska M; Zonenberg A
Endokrynol Pol; 2006; 57 Suppl A():75-81. PubMed ID: 17091461
[TBL] [Abstract][Full Text] [Related]
73. Emerging molecular markers for the prognosis of differentiated thyroid cancer patients.
Baldini E; Sorrenti S; Tuccilli C; Prinzi N; Coccaro C; Catania A; Filippini A; Bononi M; De Antoni E; D'Armiento M; Ulisse S
Int J Surg; 2014; 12 Suppl 1():S52-6. PubMed ID: 24862669
[TBL] [Abstract][Full Text] [Related]
74. Pediatric Thyroid Cancer: Postoperative Classifications and Response to Initial Therapy as Prognostic Factors.
Lazar L; Lebenthal Y; Segal K; Steinmetz A; Strenov Y; Cohen M; Yaniv I; Yackobovitch-Gavan M; Phillip M
J Clin Endocrinol Metab; 2016 May; 101(5):1970-9. PubMed ID: 26930182
[TBL] [Abstract][Full Text] [Related]
75. Potential Impact of BMI on the Aggressiveness of Presentation and Clinical Outcome of Differentiated Thyroid Cancer.
Matrone A; Ceccarini G; Beghini M; Ferrari F; Gambale C; D'Aqui M; Piaggi P; Torregrossa L; Molinaro E; Basolo F; Vitti P; Santini F; Elisei R
J Clin Endocrinol Metab; 2020 Apr; 105(4):. PubMed ID: 31875910
[TBL] [Abstract][Full Text] [Related]
76. Features and outcome of differentiated thyroid carcinoma associated with Graves' disease: results of a large, retrospective, multicenter study.
Premoli P; Tanda ML; Piantanida E; Veronesi G; Gallo D; Masiello E; Rosetti S; Cusini C; Boi F; Bulla J; Rodia R; Mariotti S; Capelli V; Rotondi M; Magri F; Chiovato L; Rocchi R; Campopiano MC; Elisei R; Vitti P; Barbato F; Pilli T; Castagna MG; Pacini F; Bartalena L
J Endocrinol Invest; 2020 Jan; 43(1):109-116. PubMed ID: 31327128
[TBL] [Abstract][Full Text] [Related]
77. Comparison of differentiated thyroid carcinoma recurrence and its clinical features in children of different ages.
Ye B; Shi J; Shen C; Wang L; Hu H; Ma Y; Wang Q; Lu J; Yu G; Xiang M
Oncotarget; 2017 Jul; 8(29):48051-48059. PubMed ID: 28624796
[TBL] [Abstract][Full Text] [Related]
78. Quality of life and anxiety in adolescents with differentiated thyroid cancer.
Oren A; Benoit MA; Murphy A; Schulte F; Hamilton J
J Clin Endocrinol Metab; 2012 Oct; 97(10):E1933-7. PubMed ID: 22791758
[TBL] [Abstract][Full Text] [Related]
79. Modified dynamic risk stratification for predicting recurrence using the response to initial therapy in patients with differentiated thyroid carcinoma.
Jeon MJ; Kim WG; Park WR; Han JM; Kim TY; Song DE; Chung KW; Ryu JS; Hong SJ; Shong YK; Kim WB
Eur J Endocrinol; 2014 Jan; 170(1):23-30. PubMed ID: 24088549
[TBL] [Abstract][Full Text] [Related]
80. Evaluating the predicted impact of changes to the AJCC/TMN staging system for differentiated thyroid cancer (DTC): A prospective observational study of patients in South East Scotland.
Hulse K; Williamson A; Gibb FW; Conn B; Nixon IJ
Clin Otolaryngol; 2019 May; 44(3):330-335. PubMed ID: 30720920
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
